Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized evaluator-blinded active-controlled study of IDT-003 gel for melasma
CTR20254689Phase 2Active
- Sponsor
- Yuxi Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IDT-003 in melasma, sponsored by Yuxi Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
IDT-003
03
Conditions
melasma
Beyond the preview
Go deeper on CTR20254689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254689.